A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia

被引:55
作者
Aliaga, L [1 ]
Mediavilla, JD [1 ]
Cobo, F [1 ]
机构
[1] Hosp Univ Virgende las Nieves, Infect Dis Unit, Granada, Spain
关键词
D O I
10.1099/0022-1317-51-7-615
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of this study was to define risk factors associated with mortality in Pseudomonas aeruginosa bactaeremia and to combine them in a clinical index predicting the risk of death. The study investigated 125 consecutive episodes of P aeruginosa bacteraemia at this hospital. Crude mortality was 34%, corresponding to 43 patients who died, with 67% of deaths, directly attributable to bacteraemia. A regression logistic model identified five variables that were independently and significantly associated with an increased risk of death: 1) hospitalisation in the intensive care unit; 2) coagulopathy; 3) septic shock; 4) age greater than or equal to65 years; and 5) the clinical condition of the patient. These variables were as recorded at the time that the first positive blood culture was obtained. The sensitivity and specificity of a prediction of death based on the model were 84% and 85%, respectively. An index score, calculated from these variables, divided patients into three groups with increasing likelihood of mortality resulting from R aeruginosa bacteraemia.
引用
收藏
页码:615 / 619
页数:5
相关论文
共 20 条
[1]  
BISBE J, 1988, REV INFECT DIS, V10, P629
[2]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[3]   Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer -: Retrospective analysis of 245 episodes [J].
Chatzinikolaou, I ;
Abi-Said, D ;
Bodey, GP ;
Rolston, KVI ;
Tarrand, JJ ;
Samonis, G .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :501-509
[4]   POLYMICROBIAL BACTEREMIA IN THE LATE 1980S - PREDICTORS OF OUTCOME AND REVIEW OF THE LITERATURE [J].
COOPER, GS ;
HAVLIR, DS ;
SHLAES, DM ;
SALATA, RA .
MEDICINE, 1990, 69 (02) :114-123
[5]  
GALLAGHER PG, 1989, REV INFECT DIS, V11, P846
[6]  
GILBERT DN, 2001, SANFORD GUIDE ANTIMI
[7]   POLYMICROBIAL BACTEREMIA [J].
HERMANS, PE ;
WASHINGT.JA .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (03) :387-+
[8]   ANTIBIOTIC-THERAPY FOR PSEUDOMONAS-AERUGINOSA BACTEREMIA - OUTCOME CORRELATIONS IN A PROSPECTIVE-STUDY OF 200 PATIENTS [J].
HILF, M ;
YU, VL ;
SHARP, J ;
ZURAVLEFF, JJ ;
KORVICK, JA ;
MUDER, RR .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (05) :540-546
[9]   GRAM-NEGATIVE BACTEREMIA .3. REASSESSMENT OF ETIOLOGY, EPIDEMIOLOGY AND ECOLOGY IN 612 PATIENTS [J].
KREGER, BE ;
CRAVEN, DE ;
CARLING, PC ;
MCCABE, WR .
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03) :332-343
[10]   Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital [J].
Kuikka, A ;
Valtonen, VV .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (10) :701-708